Ege Kimya is a leading Turkish chemicals company with operations in intermediate chemicals serving both domestic and international markets. The two acquisitions indicate Ege Kimya’s strengthening of its position as a leading regional chemical producer.
The Venator transaction includes the transfer of product formulations, trademarks such as NUODEX®, and technical know-how associated with its driers business, historically operated at Venator’s Birtley, UK site. Through the acquisition of Metal Oksit, one of Türkiye’s leading zinc oxide producers, Ege Kimya further strengthens its portfolio of products serving as key raw materials for industries such as tire, rubber, ceramics, cosmetics, paint and agriculture. Completion of the Metal Oksit acquisition remains subject to the satisfaction of customary conditions precedent.
Paksoy is pleased to announce that a team led by partner Ayşe Demirel Atakan and associates Meriç Saçak Albaş and Tuna Çıtır advised Ege Kimya on these transactions.
Share
Related persons
You can contact us for detailed information.


Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
19 January 2026
Paksoy advises Amphenol on its acquisition of CommScope’s CCS business
Paksoy advises Amphenol Corporation on its acquisition of CommScope’s Connectivity and Cable Solutions (CCS) business.
14 January 2026
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ.
13 January 2026
Paksoy advised IFC on its investment in Getmobil
Paksoy advised IFC on its investment in Getmobil.
12 January 2026
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025, advising on USD 4.97 billion across 18 transactions.
7 January 2026
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility.
5 January 2026
We are pleased to announce the promotion of Sabri Kaya to Counsel, effective as of 1 January 2026
We extend our congratulations to Sabri Kaya on his well-deserved promotion to Counsel.
